New research from charity Parkinson’s UK and Sheffield Hallam University, UK, has revealed that thousands of people affected by Parkinson’s are struggling with financial losses of more than £16,000 each year
Thousands of people affected by Parkinson’s are struggling with financial losses of more than £16,000 every year, according to new research published by Sheffield Hallam University and Parkinson’s UK.
The report – ‘The Cost of Parkinson’s: the financial impact of living with the condition’ – shows that a household where a person is living with the condition loses an average of £319 per week due to reduced income plus an increase in living costs. This is 60% more than previously thought.
Half of those diagnosed with Parkinson’s, and one third of their family members, have reduced working hours. Overall, households affected by the condition experience a reduction of income averaging more than £10,000 per year.
The hidden price of Parkinson’s is a result of:
– being unable to work or having to take early retirement (£6,013)
– a reduction in working hours by the person affected and/or by their carer (£1,981)
– family members providing unpaid care without financial support (£1,235)
– discontinuance of state benefits and pensions (£1,502)
– mounting health and social care costs, which total an average of £5,851 per year:
assistance for daily living, such as transport and personal care (£2,088)
energy costs (£572)
healthcare related equipment and travel (£1959)
adaptations to the home (£525).
Steve Ford, chief executive at Parkinson’s UK, said: “For the first time, this research has exposed the full financial impact of Parkinson’s, and it’s shocking that people affected by the condition are being hit by such devastating losses – especially at a time when families are already feeling the strain.
“People are being penalised by heavily reduced incomes and forced to pay for a lifetime of mobility aids, home alterations and care costs – all while battling a debilitating progressive condition, for which there is no cure.”
Anna Cunningham is 46 and lives in Dundee, Scotland. She was diagnosed with Parkinson’s in 2013 and was forced to retire from her role as healthcare assistant, due to her symptoms.
Anna said: “Being diagnosed with Parkinson’s was a total shock. I was told I needed to retire early and it hit me like a ton of bricks.
“I have a small NHS pension, which brings in about £200 a month, and my husband works part time at the hospital, so financially it was very hard straight away.”
The report also highlights a reduction in quality of life for people with Parkinson’s as the condition progresses. Most respondents with Parkinson’s had seen a decline in their health over the previous year, with two-thirds needing help with activities inside and outside the home.
In addition, it showed a worrying impact on general wellbeing. More than 60% of people with Parkinson’s and 55% of carers who were questioned, reported low life satisfaction.
Parkinson’s UK is calling on the government to make changes to welfare support and increase social care investment, as well as proposing new policies and practices for employers, to help people affected by Parkinson’s stay in work for as long as possible.
Steve Ford continued: “This report has uncovered an impossible scenario being faced by thousands of people affected by Parkinson’s. Every day, people are being forced to choose between being out of pocket, or sacrificing their health – and it’s having a significant impact on their wellbeing. More must be done to address inconsistencies in services and funding available to households affected by the condition across the UK.
“With a stretched NHS and social care services, and changes to welfare support, it is crucial that the government works with us, and people affected by Parkinson’s, to develop solutions and improve the public services we all rely on.”
Dr Anil Gumber, principal investigator at Sheffield Hallam University’s Faculty of Health and Wellbeing, said: “People affected by Parkinson’s and their informal carers, need support from the point of diagnosis to better understand the condition, and help plan how they cope in the long term.
“Our research has highlighted that there continue to be inconsistencies in the provision of services, and funding accessible to people with Parkinson’s across the UK and this needs to be rectified to ensure there is consistent provision of care from diagnosis across the health, social care and independent sectors.”
Image credits: Parkinson’s UK
Read and/or download the full report from the Parkinson’s UK website
Providing free speech therapy for New York’s Parkinson’s community
We talk to student clinician Beata Royzman about speech therapy for Parkins
4 days ago
Parkinson’s disease in three words – and other highlights of our Christmas special
What has Parkinson’s given you – and what has it taken away? This is just one of the questions to look out for in our podcast’s upcoming Christmas special. In this episode, we’ll bring together voices from across the podcast, as guests share their unique perspectives on three prompts about life with the condition: Describe Parkinson’s disease in three words. What gets you through the day? What has Parkinson’s given you – and what has it taken away? For many people, the start of a new year offers an opportunity for reflection – so as we look forward to this episode, we invite our readers to share their own answers to the questions above. If you’d like to share your answers with us, or if you’re interested in taking part in future episodes, get in touch through Facebook, Twitter or by emailing email@example.com. We look forward to hearing from you!
Wearable device for Parkinson’s disease raises $10m in funding
UK-based tech company Charco Neurotech has secured $10 million in seed investment funding to support the launch of a non-invasive wearable device designed for people with Parkinson’s disease. CUE1 is a circular device worn on the sternum, which is designed to help alleviate Parkinson’s symptoms through specialised vibrations that are personalised for each patient. The investment round, which was co-led by venture capital company Amadeus Capital Partners and growth fund managers Parkwalk Advisors, is the largest European seed financing in 2021 for a heath technology device – and the sixth largest globally. Lucy Jung, co-founder and CEO of Charco Neurotech, said: “This funding will enable us to proceed with our first, limited launch, while we work to ensure our manufacturing line is robust and produces consistent high quality devices.” Charco also recently announced a new partnership with the European Parkinson’s Disease Association (EPDA), to help increase the availability of Charco’s…
An international team led by the University of Ottawa in Canada will study whether the scent-processing nerves inside the nose may play a part in the development of Parkinson’s disease. The researchers will explore potential connections between inflammation, environmental exposures in the nasal cavity, odour processing centres in the brain and Parkinson’s-related genes. The scientists hope that if the study indicates that Parkinson’s starts in the nose, early signs of the condition could potentially be detected sooner. This research, which will use human and animal models, has been made possible by a US $9m grant from the Aligning Science Across Parkinson’s (ASAP) initiative, which aims to improve understanding of the causes of the condition. “This grant will allow us to explore an understudied but important aspect of Parkinson’s, which could lead to new approaches for early treatment and prevention,” said Professor Michael Schlossmacher, team leader of the study.